IM Cannabis Corp. (IMCC)
| Market Cap | 6.51M |
| Revenue (ttm) | 37.61M |
| Net Income (ttm) | -3.37M |
| Shares Out | 5.25M |
| EPS (ttm) | -0.97 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 27,421 |
| Open | 1.260 |
| Previous Close | 1.310 |
| Day's Range | 1.220 - 1.315 |
| 52-Week Range | 1.200 - 7.120 |
| Beta | 2.02 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2025 |
About IMCC
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel. [Read more]
Financial Performance
In 2024, IM Cannabis's revenue was 54.03 million, an increase of 10.71% compared to the previous year's 48.80 million. Losses were -10.59 million, 11.4% more than in 2023.
Financial numbers in CAD Financial StatementsNews
IM Cannabis Reports Third Quarter 2025 Financial Results
TORONTO and GLIL YAM, Israel , Nov. 13, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC), an international medical cannabis company, announced its financial results today...
IM Cannabis to Report third Quarter 2025 Financial Results on Thursday, November 13th at 9:00am ET
TORONTO and GLIL YAM, Israel , Nov. 6, 2025 /PRNewswire/ -- IM Cannabis Corp. (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and G...
IM Cannabis Announces CFO Departure
TORONTO and GLIL YAM, Israel , Oct. 29, 2025 /PRNewswire/ -- IM Cannabis Corp. (NASDAQ: IMCC) (the "Company", "IM Cannabis", or "IMC"), a leading international medical cannabis company with operations...
Cannabis Investing 2025: 3 Pot Stocks to Watch Before November
The cannabis industry continues to evolve as investors prepare for potential U.S. federal reform and international market expansion. Despite short-term volatility, global demand for both medical and r...
IM Cannabis Signs Non-Binding Term Sheet to Acquire 60% Stake in Innovative Quantum Computing Bio Data Company for Up to $54 Million
TORONTO and GLIL YAM, Israel , Oct. 23, 2025 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ: IMCC), a leading medical cannabis company with operations in Israel and Germany, today ...
IM Cannabis Announces Board Changes and Strategic Decision to Identify Additional Business Opportunities
TORONTO and GLIL YAM, Israel , Sept. 16, 2025 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, today...
IM Cannabis Regains Compliance with Nasdaq Stockholders' Equity Listing Requirement
TORONTO and GLIL YAM, Israel , Sept. 5, 2025 /PRNewswire/ -- IM Cannabis Corp. (NASDAQ: IMCC) (the "Company", "IM Cannabis", or "IMC"), a leading medical cannabis company with operations in Israel and...
IM Cannabis Announces Warrant Amendments and Form F-3 Resale Registration Statement Filing
TORONTO and GLIL YAM, Israel , Aug. 13, 2025 /PRNewswire/ -- IM Cannabis Corp. ("IM Cannabis" or the "Company") (NASDAQ: IMCC), a leading medical cannabis company with operations in Israel and Germany...
IM Cannabis Reports Second Quarter 2025 Financial Results
IMC Delivers Strong Profit and Margin Growth Despite Revenue Impact from External Challenges in Q2 2025 TORONTO and GLIL YAM, Israel , Aug. 12, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or...
IM Cannabis to Report Second Quarter 2025 Financial Results on Tuesday, August 12th at 9:00am ET
TORONTO and GLIL YAM, Israel , Aug. 4, 2025 /PRNewswire/ -- IM Cannabis Corp. (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and G...
IM Cannabis Closes Private Placement for Gross Proceeds of Approximately US$4.1 Million
TORONTO and GLIL YAM, Israel , July 31, 2025 /PRNewswire/ -- IM Cannabis Corp. ("IM Cannabis" or the "Company") (NASDAQ: IMCC), a leading medical cannabis company with operations in Israel and Germany...
IM CANNABIS ANNOUNCES FILING OF SHELF REGISTRATION STATEMENT ON FORM F-3
TORONTO and GLIL YAM, Israel , July 11, 2025 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, is ple...
IM Cannabis Announces the Signing of a Loan Agreement and Appointment of Oz Adler to Board of Directors
TORONTO and GLIL YAM, Israel, July 9, 2025 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleas...
IM Cannabis Provides Corporate Updates
TORONTO and GLIL YAM, Israel , July 1, 2025 /PRNewswire/ -- IM Cannabis Corp. (NASDAQ: IMCC) (the "Company", "IM Cannabis", or "IMC"), a leading medical cannabis company with operations in Israel and ...
CSE Bulletin: Delist - IM Cannabis Corp. (IMCC)
Toronto, Ontario--(Newsfile Corp. - Le 28 mai/May 2025) - The common shares of IM Cannabis Corp. (the "Issuer") will be delisted from the CSE at market close, June 2, 2025. The Issuer will continue to...
IM Cannabis Announces Plans to Voluntarily Delist from the Canadian Securities Exchange
TORONTO and GLIL YAM, Israel , May 28, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announces that it has appl...
IM Cannabis Corp. (IMCC) Q1 2025 Earnings Call Transcript
IM Cannabis Corp. (NASDAQ:IMCC) Q1 2025 Earnings Call May 15, 2025 9:00 AM ET Company Participants Anna Taranko - Director, Investor and Public Relations Oren Shuster - Chief Executive Officer Uri Bi...
IM Cannabis Reports First Quarter Financial Results
IMC Delivers Net Profit and 87% Gross Margin Improvement in Q1, Reflecting Strategic and Operational Progress TORONTO and GLIL YAM, Israel , May 15, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Compan...
IM Cannabis Announces Filing of Information Circular for Upcoming Annual General and Special Meeting and Provides Additional Information on the Focus Transaction
TORONTO and GLIL YAM, Israel , May 7, 2025 /PRNewswire/ -- IM Cannabis Corp. (Nasdaq: IMCC) (CSE: IMCC) (the "Company" or "IM Cannabis"), a leading medical cannabis company with operations in Israel a...
IM Cannabis to Report First Quarter 2025 Financial Results on Thursday, May 15th at 9:00am ET
TORONTO and GLIL YAM, Israel , May 6, 2025 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in I...
IM Cannabis Corp. (IMCC) Q4 2024 Earnings Call Transcript
IM Cannabis Corp. (NASDAQ:IMCC) Q4 2024 Earnings Conference Call March 31, 2025 9:00 AM ET Company Participants Anna Taranko - Director of Investor and Public Relations Oren Shuster - Chairman and Ch...
IM Cannabis Reports Fourth Quarter and Full Year 2024 Financial Results
Q4 2024 Caps a Year of Strategic and Operational Improvements for IMC with 25% Revenue Growth, 42% decrease in Operating Expenses, and $0.5M Adjusted EBITDA Profit TORONTO and GLIL YAM, Israel , March...
IM Cannabis to Report Fourth Quarter and Full Year 2024 Financial Results on Monday, March 31 2025 at 9:00am ET
TORONTO and GLIL YAM, Israel , March 20, 2025 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations i...
IM Cannabis Announces Change of Auditors
TORONTO and GLIL YAM, Israel, Jan. 17, 2025 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ: IMCC) (CSE: IMCC), a leading medical cannabis company with operations in Israel and Germ...
IM Cannabis Corp. (IMCC) Q3 2024 Earnings Call Transcript
IM Cannabis Corp. (NASDAQ:IMCC) Q3 2024 Earnings Conference Call November 14, 2024 9:00 AM ET Company Participants Anna Taranko - Director of Investor and Public Relations Oren Shuster - Chief Execut...